Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for assessing peripheral neuropathy response to cancer treatment

Biomarkers for assessing peripheral neuropathy response to cancer treatment

US Patent 9605317 · Granted Mar 28, 2017

Estimated economic value: $74,801,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Detection of human umbilical cord tissue-derived cells2020
Detection of human umbilical cord tissue-derived cells2020
System and method for fetal and maternal red blood cell counting2019
Method of designing addressable array suitable for detection of nucleic acid seq2018
Method for the treatment of depression2018
Assay for predictive biomarkers2018
Method of designing addressable array suitable for detection of nucleic acid seq2017
Detection of human umbilical cord tissue derived cells2017
Detection of human umbilical cord tissue derived cells2017
System and method for fetal and maternal red blood cell counting2017
Method of designing addressable array suitable for detection of nucleic acid seq2016
Predictors for cancer treatment2016